Thus, while wild‐type p53 suppresses TSPAN8 expression 46, its somatic mutations occurring in breast cancer 48 may be one of the reasons for the re‐expression of TSPAN8 in a portion of breast cancer cells in primary lesions or metastases. Here, TP53 is linked to breast cancer.